Today: 21 May 2026
Ondas Holdings stock in focus after $1 billion premium stock-and-warrant sale
11 January 2026
2 mins read

Ondas Holdings stock in focus after $1 billion premium stock-and-warrant sale

NEW YORK, Jan 10, 2026, 18:42 EST — Market closed.

  • Ondas shares dropped 2.3% on Friday following the announcement of a $1 billion stock-and-warrant offering
  • The deal carries a premium over the previous close, with closing anticipated near Jan. 12
  • Traders have their eyes on the U.S. CPI release set for Jan. 13, followed by Ondas management’s investor presentations from Jan. 14 to 16

Ondas Holdings Inc (ONDS) shares slid 2.3% to close at $13.69 on Friday, bouncing between $15.10 and $13.59 throughout the session as the market absorbed news of the company’s $1 billion financing deal.

The raise is sizable by Ondas’ standards. It gives the company new ammunition for deals and growth just as interest in defense and security-focused drone stocks heats up, though it also quickly boosts the potential share count.

The mix matters now, given the financing includes a heavy load of warrants—rights to purchase stock later at a set price—and management is set to unveil more details of its 2026 plan in the next few days. If that narrative falters, the stock could suffer.

Ondas priced a registered direct offering of 19 million common shares plus pre-funded warrants for up to 41.79 million shares. The deal also includes warrants allowing buyers to purchase two shares for each share equivalent sold. The combined price came in at $16.45 per share-plus-warrant, roughly 17.5% above the Jan. 8 closing price. The transaction is slated to close on or around Jan. 12.

The company said the common stock warrants have a $28 exercise price and will last seven years. If all are exercised for cash, Ondas could pull in roughly $3.4 billion, though it warned there’s no guarantee this will happen. Proceeds are targeted for corporate development and strategic growth efforts, such as acquisitions, joint ventures, and investments. Oppenheimer is serving as the lead placement agent.

A registered direct offering involves selling securities straight to an investor under a shelf registration already filed with the U.S. Securities and Exchange Commission. Pre-funded warrants come into play when buyers want nearly all the economic benefits of a share upfront but postpone full issuance, usually to navigate ownership caps.

In a separate regulatory filing, Ondas disclosed unaudited, preliminary financial data for Sentry CS Ltd, the Israeli counter-drone firm it bought in November. The filing reported Sentry’s projected 2024 sales at $11.35 million, with a net loss of $13.51 million, noting these figures await finalization through financial closing procedures.

Ondas offers autonomous systems and private wireless solutions via its business units, Ondas Autonomous Systems and Ondas Networks, according to its company profile.

The investor calendar is packed. Ondas announced that CEO Eric Brock will join Needham’s defense tech analyst Austin Bohlig for a fireside chat at 8:45 a.m. ET on Jan. 14, taking place during the Needham Growth Conference.

Ondas Holdings Inc. will hold a virtual investor day at 10:00 a.m. ET on Jan. 16, just two days from now. Management plans to deliver a financial update and outline their 2026 outlook, followed by a Q&A session.

Macro data remains a potential market mover. The U.S. CPI for December 2025 drops at 8:30 a.m. ET Tuesday, Jan. 13. The following day, Wednesday, Jan. 14, brings the November 2025 Producer Price Index, also at 8:30 a.m. ET. The Federal Reserve’s next policy meeting is set for Jan. 27–28.

Traders will closely watch if Ondas can stay above Friday’s $13.59 low and reclaim the $15 level it reached earlier that day. The stock closed at $13.69 on Friday, still under Thursday’s $14.01 finish—a mark many short-term traders see as a crucial threshold.

The downside is clear. Despite a headline premium, the deal brings significant dilution risk and a warrant overhang, while the stock’s recent volatility can work against shareholders when liquidity dries up. Execution risk is still on the table—investors will need to see concrete evidence that the cash converts into revenue without triggering further financings.

Monday marks the market’s first chance to gauge any follow-through once trading kicks back in, with the Jan. 12 close serving as the immediate checkpoint. The management events slated for Jan. 14–16 are set to drive the next wave of activity. Ondas hasn’t confirmed its next earnings date, but Zacks pins it around March 11.

Stock Market Today

  • Sudarshan Colorants India's Earnings Show Potential Despite Profit Dip
    May 20, 2026, 8:53 PM EDT. Sudarshan Colorants India Limited (NSE:SUDARCOLOR) reported weaker profits last quarter, impacted by ₹50 million in unusual expenses that are unlikely to recur, suggesting potential profit rebound. The company's earnings per share (EPS) are growing strongly, indicating solid underlying business performance. Investors should consider balance sheet strength and monitor two identified warning signals, one considered significant. While profit was soft this time, analysts view Sudarshan Colorants' earnings outlook as cautiously optimistic, citing quality income statement elements and possible earnings improvements in the next quarter.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Previous Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week
Next Story

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

Go toTop